Innoviva, Inc. reports

Company location: Burlingame, CA
Fiscal year end: 31 December

Innoviva, Inc. has filed 1,661 SEC EDGAR filings since 21 Mar 2000

Filter by type:
10-K
10-Q
8-K
SC13D
SC13G

SEC filing history

Showing 826-850 of 1,000 matching filings.

Per page

25

Current page

34

4

FORM 4 -

Filing date: 21 Apr 2014
Reporting date: 17 Apr 2014
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 000-30319

8-K

Filing date: 21 Apr 2014
Reporting date: 17 Apr 2014
SEC evidence: Open document Open filing
Next action: Verify source filing

CORRESP

CORRESP filing

Filing date: 15 Apr 2014
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

DEF 14A File 000-30319

DEF 14A

Filing date: 15 Apr 2014
Reporting date: 22 May 2014
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 -

Filing date: 09 Apr 2014
Reporting date: 07 Apr 2014
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 000-30319

8-K

Filing date: 09 Apr 2014
Reporting date: 09 Apr 2014
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 -

Filing date: 02 Apr 2014
Reporting date: 31 Mar 2014
SEC evidence: Open document Open filing
Next action: Verify source filing

UPLOAD

UPLOAD filing

Filing date: 02 Apr 2014
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 -

Filing date: 25 Mar 2014
Reporting date: 21 Mar 2014
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 000-30319

THERAVANCE, INC. 8-K

Filing date: 24 Mar 2014
Reporting date: 24 Mar 2014
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 000-30319

THERAVANCE, INC. 8-K

Filing date: 18 Mar 2014
Reporting date: 13 Mar 2014
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 000-30319

THERAVANCE, INC. 8K

Filing date: 14 Mar 2014
Reporting date: 14 Mar 2014
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 000-30319

THERAVANCE, INC. 8K

Filing date: 13 Mar 2014
Reporting date: 13 Mar 2014
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 -

Filing date: 10 Mar 2014
Reporting date: 06 Mar 2014
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 -

Filing date: 10 Mar 2014
Reporting date: 06 Mar 2014
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K/A File 000-30319

8-K/A

Filing date: 06 Mar 2014
Reporting date: 03 Mar 2014
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 -

Filing date: 05 Mar 2014
Reporting date: 03 Mar 2014
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 000-30319

8-K

Filing date: 03 Mar 2014
Reporting date: 03 Mar 2014
SEC evidence: Open document Open filing
Next action: Verify source filing

10-K File 000-30319

10-K

Filing date: 03 Mar 2014
Reporting date: 31 Dec 2013
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

FORM 4 -

Filing date: 24 Feb 2014
Reporting date: 20 Feb 2014
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 -

Filing date: 24 Feb 2014
Reporting date: 20 Feb 2014
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 -

Filing date: 24 Feb 2014
Reporting date: 20 Feb 2014
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 -

Filing date: 24 Feb 2014
Reporting date: 20 Feb 2014
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 -

Filing date: 24 Feb 2014
Reporting date: 20 Feb 2014
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 -

Filing date: 24 Feb 2014
Reporting date: 20 Feb 2014
SEC evidence: Open document Open filing
Next action: Verify source filing

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .